Submitted by Anonymous (not verified) on 7 May 2026 - 15:34
Human medicines European public assessment report (EPAR): Ambrisentan Viatris (previously Ambrisentan Mylan), ambrisentan, Date of authorisation: 20/06/2019, Revision: 9, Status: Authorised
Source: